Table 2.
Body mass index (BMI) stratified by selected demographic and medical history factors in a population-based cohort of men from King County, WA
| BMI Category | p-value | |||
|---|---|---|---|---|
| Characteristic | < 25 | 25 – 29.9 | ≥ 30 | |
| N (%) | N (%) | N (%) | ||
| Age | ||||
| 40 – 49 | 22 (10.0) | 34 (9.4) | 19 (10.1) | 0.30 |
| 50 – 54 | 26 (11.9) | 46 (12.7) | 21 (11.1) | |
| 55 – 59 | 43 (19.6) | 65 (17.9) | 41 (21.8) | |
| 60 – 64 | 34 (15.5) | 71 (19.6) | 45 (25.0) | |
| 65 – 69 | 47 (21.5) | 78 (21.5) | 38 (20.2) | |
| 70 – 74 | 47 (21.5) | 69 (19.0) | 22 (11.7) | |
| Race | ||||
| Caucasian | 203 (92.7) | 338 (93.1) | 163 (86.7) | 0.03 |
| African-American | 16 (7.3) | 25 (6.9) | 25 (13.3) | |
| Family history of prostate cancer+ | ||||
| No | 192 (87.7) | 314 (86.5) | 173 (92.0) | 0.16 |
| Yes | 27 (12.3) | 49 (13.5) | 15 (8.0) | |
| Diabetes mellitus | ||||
| No | 209 (95.4) | 333 (91.7) | 151 (80.3) | < 0.001 |
| Yes | 10 (4.6) | 30 (8.3) | 37 (19.7) | |
| BPH* | ||||
| No | 163 (74.4) | 282 (77.7) | 154 (81.9) | 0.19 |
| Yes | 56 (25.6) | 81 (22.3) | 34 (18.1) | |
| Statin use (current) | ||||
| No | 178 (81.3) | 261 (71.9) | 139 (73.9) | 0.04 |
| Yes | 41 (18.7) | 102 (28.1) | 49 (26.1) | |
| Aspirin use (current) | ||||
| No | 124 (56.6) | 186 (51.2) | 105 (55.9) | 0.34 |
| Yes | 95 (43.4) | 177 (48.8) | 83 (44.2) | |
| Other NSAID use (current) | ||||
| No | 197 (90.0) | 314 (86.5) | 154 (81.9) | 0.06 |
| Yes | 22 (10.0) | 49 (13.5) | 34 (18.1) | |
| Aspirin or Other NSAID use (current) | ||||
| No | 112 (51.1) | 162 (44.6) | 90 (47.9) | 0.31 |
| Yes | 107 (48.9) | 201 (55.4) | 98 (52.1) | |
| Thiazide use | ||||
| No | 208 (95.0) | 329 (90.6) | 167 (88.8) | 0.07 |
| Yes | 11 (5.0) | 34 (9.4) | 21 (11.2) | |
+
First-degree relative diagnosed with prostate cancer
*
Self-reported history of a physician’s diagnosis of benign prostatic hyperplasia